South Africa Allergy Diagnostics And Therapeutics Market Size & Outlook
South Africa allergy diagnostics and therapeutics market, 2018-2030 (US$M)
Related Markets
South Africa allergy diagnostics and therapeutics market highlights
- The South Africa allergy diagnostics and therapeutics market generated a revenue of USD 293.3 million in 2023 and is expected to reach USD 454.9 million by 2030.
- The South Africa market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
- In terms of segment, inhaled was the largest revenue generating allergen type in 2023.
- Other Allergens is the most lucrative allergen type segment registering the fastest growth during the forecast period.
Allergy diagnostics and therapeutics market data book summary
| Market revenue in 2023 | USD 293.3 million |
| Market revenue in 2030 | USD 454.9 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Inhaled |
| Fastest growing segment | Other Allergens |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaled, Drug, Other Allergens, Food |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.9% of the global allergy diagnostics and therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia allergy diagnostics and therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 236.0 million by 2030.
Inhaled was the largest segment with a revenue share of 55.1% in 2023. Horizon Databook has segmented the South Africa allergy diagnostics and therapeutics market based on inhaled, drug, other allergens, food covering the revenue growth of each sub-segment from 2018 to 2030.
The South Africa allergy diagnostics and therapeutics market is competitive owing to the local presence of multiple global players and domestic manufacturers. The shortage of allergists in the country is a key concern for the growth of allergy diagnostics and therapeutics market. Rising number of R&D activities is one of the key factors driving the market expansion.
AMPATH is among the largest private pathology providers in the country and offers the most intensive diagnostic services for allergies. The company offers the most advanced technologies for diagnostics and also offers centralized allergy testing. This will offer favorable opportunities for the expansion of the market for allergy treatments. Furthermore, increasing launch and approval of drugs are expected to boost the market expansion.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa allergy diagnostics and therapeutics market size, by allergen type, 2018-2030 (US$M)
South Africa Allergy Diagnostics And Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
